Links to other pages within Patient UK which are related to this topic:
Experience | Leaflets | Support | Patient+ | Guidelines | Weblinks | Poems | Videos | News | Products | Other
Print options:   Other options:   (what's this?)

This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Pain Control in Terminal Care

Pain is a common and feared symptom in the dying.

It is not inevitable. It occurs in up to 70% of patients with advanced cancer and about 65% of patients dying of non-malignant disease.1 Much can now be done medically to make their last few weeks or months relatively pain-free. An average GP will have 10 patients receiving terminal care each year, 5 of them dying of cancer, and good palliative care can make a huge difference to the quality of an individual's end of life.

Terminally ill patients often report that they fear intractable pain more than they do dying. Patients frequently express the desire to have open and honest dialogue with medical carers about pain and want to be involved fully in planning their pain management.2,3 A doctor must be able to get alongside the patient and their family and to spend time presenting options, answering questions and quelling fears. Having promised to keep the patient relatively pain-free, it is paramount to meet this promise to preserve trust. Pain is easier to prevent than it is to relieve and drugs should be prescribed on a prophylactic basis with no other consideration than maintaining the patient's quality of life.

Pain is a complex subjective phenomenon and is affected by the emotional context in which it is endured. Adequate psychological support is critical as removing the fear of pain in itself will help to optimise pain control. A patient who is fearful, withdrawn and depressed often appears to have a lower pain threshold than one who is still actively engaged in enjoying what is left of their lives, even though they may have same stage disease. Non-drug measures to help psychological or spiritual distress may be as important as medication in relieving pain and suffering.

Whilst pain relief is vital, good palliative care encompasses far more. Within primary health care teams, improving the quality of palliative care can be facilitated by the Gold Standard Framework.4 Similarly, good practice is outlined in the Liverpool Care Pathway for the Dying,5 which provides an important resource for those caring for those at the end of life. Good communication within and between teams is vital, eg between primary and secondary care and between usual daytime GP and out-of-hours provision, to avoid unnecessary problems during this period.

Principles of pain control in terminal care

Over 80% of cancer pain can be controlled with inexpensive oral drugs given a good assessment of pain and systematic choices of analgesics.6

  • Always try to diagnose the cause of the pain - make a full assessment of all contributing factors.
  • Explain the mechanism underlying the pain to the patient and agree on treatment goals.
  • Use the WHO analgesic ladder to guide systematic pain-relief but remember other treatments (surgery, nerve blocks, radiotherapy etc) and non-drug treatments may also have a role.

    WHO analgesic ladder

    Step 1 Non-opioid+/-adjuvant
    Pain persisting or increasing?
    Step 2 Opioid for mild to moderate pain +/-non-opioid +/-adjuvant
    Pain persisting or increasing?
    Step 3 Opioid for moderate to severe pain+/-non-opioid +/-adjuvant
    Objective: Freedom from pain

  • Base the choice of drug on the severity of pain and not the stage of disease. Step up to strong opioids when step 1 and 2 analgesics have failed.
  • Adjuvant analgesics may be usefully added at any stage.

    Common adjuvant analgesics for cancer pain 6

    Drugs Indications
    Non-steroidal anti-inflammatories
    • Bone pain
    • Soft tissue infiltration
    • Hepatomegaly
    Corticosteroids
    • Raised intracranial pressure
    • Soft tissue infiltration
    • Nerve compression
    • Hepatomegaly
    Antidepressants and anticonvulsants
    • Nerve compression or infiltration
    • Paraneoplastic neuropathies
    Bisphosphonates
    • Bone pain

  • Prescribe not only to cover continuous background pain felt by the patient but also for breakthrough or incident pain that occurs with everyday activities such as walking. Explain that additional medication should be taken before undertaking a potentially pain-provoking activity. The aim is keep the patient pain-free both when sitting at home but also when undertaking normal daily activities.
  • Keep the treatment as simple as possible. Aim to use the minimum number of drugs in the most acceptable form and dose intervals possible. Provide written guidance for the patient and family to reinforce the drug regimen.
  • Regular review is essential to ensure that treatment goals are being met, side-effects avoided etc.
  • Use anticipatory prescribing to avoid delay in response to a symptom which may predictably occur due to disease progression. Ensure adequate prn medications. Availability of equipment and drugs needs to be assured, particularly out-of-hours, so always anticipate changes with patients, district nursing teams, community pharmacists etc to avoid delays and unnecessary suffering.
Analgesia

Non-opioids

  • Paracetamol is a weak analgesic with very few side effects.
  • NSAIDs are particularly useful for bone pain that is often poorly controlled by opioids. Their main side effect is GI bleeding - often a PPI is co-prescribed to counter this risk.

Weak opioids

These are used when non-opioids are ineffective. These include codeine phosphate and dihydrocodeine tartrate and are often used in combination with paracetamol.

Strong opioids

Oral morphine

This forms the backbone of first-line therapy. Patients and family are commonly concerned at the outset and it needs to be explained that morphine is an effective analgesic, conferring overall benefit and does not imply imminent death. Other common myths and misunderstandings include:

  • It is not normally addictive. Patients commonly reduce their dose if other measures counter the cause of the pain.
  • Respiratory depression is not usually a problem. Pain tends to counteract this effect even in those with respiratory disease and it is useful for symptomatic relief of dyspnoea.
  • Significant tolerance to morphine does not usually develop. Patients are normally maintained for several weeks on a constant dose and this is only increased because of advancing disease.
  • Morphine is not stupefying. At the correct dose patients can continue with normal activities. Always warn patients that initial sedation may occur but that it usually settles within 48 hours.

Dose titration

  • Initially give 4 hourly as normal release tablets or elixir.
  • Allow extra doses of the same size for 'breakthrough pain' as required.
  • After 24 hours total the previous day's intake and divide by 6 to provide 4 hourly doses, thus adjusting the regular dose upwards if needed.
  • A regular four hourly starting dose for opioid naive patients is usually 5-10 mg.
  • Patients who have already been using weak opioids should not be considered opioid naive - codeine and dihydrocodeine are 1/10 morphine's potency and tramadol 1/5 morphine's potency and starting dose should be calculated on the basis of previous requirements.

Maintenance dose

  • Once pain relief is at a satisfactory and stable level, sustained release preparations can be substituted to allow od or bd dosing.
  • Any breakthrough pain not associated with unusual activity should be treated with morphine elixir or ordinary tablets at 1/6 total daily dose. Review the daily dose of sustained release morphine and increase by anything from 30% to 100%. Remember that the aim is prevent pain occurring rather than relieving it.

Common side-effects

Use the lowest necessary dose for full analgesic effect to minimise side-effects.

  • Sedation - usually subsides within a few days.
  • Nausea and vomiting - common in opioid-naive patients. Usually settles within a few days but can be prevented using anti-emetics (eg metoclopramide 10 mg tds or haloperidol 1.5 mg or nocte).
  • Constipation - very common and laxatives should be prescribed prophylactically.
  • Dry mouth - advise good mouth care: frequent sips of iced drinks, dental floss, saliva replacements or stimulants.
  • Pruritis - related to histamine release. Try oral antihistamine to control itch.
  • Bronchoconstriction - again related to histamine release. Use i.v./i.m. antihistamine and bronchodilators and switch to a pharmacologically distinct opioid such as methadone.
  • Toxicity - appears as agitation, hallucinations, confusion, vivid dreams and myoclonic jerks. Worsening renal or hepatic function will alter the metabolism of morphine and may cause accumulation and toxicity. Consider adjusting dose downwards or increasing dose interval.

Parenteral routes

Syringe drivers
  • If vomiting, dysphagia or increasing weakness prevent patients from taking oral morphine, then usual practice is to convert to a subcutaneous infusion of opioid via a device such as a syringe driver. Injection site should be changed every 2-3 days.
  • Diamorphine is approximately 3 times as powerful as oral morphine as an analgesic. Subcutaneous morphine can be used in its place when diamorphine is not available and is twice the potency of oral morphine. Daily doses for the syringe driver, when moving from tablets to subcutaneous infusion, are simple to calculate.7

Examples of equivalent doses:

Daily dose oral morphine (mg) Daily dose subcut diamorphine (mg) Daily dose subcut morphine (mg)
180 60 90
300 100 150

Many other drugs can be mixed with diamorphine in the syringe driver to help with nausea and vomiting, restlessness etc but check compatibility first.

Transdermal fentanyl

An alternative to both oral morphine and s.c. diamorphine is transdermal fentanyl patches. They can be useful in ambulatory patients where:

  • Problems with the oral route
  • Intractable constipation
  • Morphine intolerance

Fentanyl is a very powerful synthetic opioid (150x potency of oral morphine). It diffuses across the skin to provide a continuous level of analgesia without tablets or needles.They are, however, comparatively expensive.8

  • Patches are worn for 72 hours.
  • Time for the drug to take effect or to clear from the body needs to be allowed. Steady-state of fentanyl is achieved after 36-48 hours and minimal effective plasma concentration from 3-23 hours (note large individual differences), therefore rescue medication will be necessary particularly in the first 24 hours.
  • Only use with patients whose pain is stable because of the long time needed to titrate the dose upwards.
  • If effective analgesia lasts less than 3 days, increase the patch strength rather than the frequency of patch changes.
  • After removing a patch, elimination plasma half-life is almost 24 hours so care should be taken not to overdose.9
Common problems

About 10% terminal patients have 'difficult pain'.1 Pain that is difficult to control is often:

  • Poorly responsive to opioids
  • Episodic and breaks through despite background opioid analgesia
  • Caused or aggravated by non-physical factors

Morphine intolerance

Factors affecting the ability to tolerate opioids include:

  • Responsiveness of the pain to opioids
  • Previous exposure to opioids
  • Rate of dose titration
  • Additional medication
  • Concomitant disease
  • Genetic factors
  • Renal & hepatic function

Strategies for improving tolerance include:

  • Start with a low initial dose of opioid and titrate slowly upwards. Avoid inducing tolerance or toxicity unnecessarily.
  • Use short-acting preparations until dose is stabilised.
  • Pain may appear to be morphine-resistant if underdosing (insufficient dose, not taken by the clock, taken prn).
  • Consider if agitated confusion is due to opioid toxicity rather than uncontrolled pain before giving further opioids
  • Consider switching to an alternative opioid such as methadone. Methadone's receptor binding profile differs from that of pure μ-agonists and often gives better analgesia and reduced side-effects. Other possibilities include hydromorphine and oxycodone.
  • Manage side-effects with additional medication.
  • Consider changing the route of administration eg where GI absorption is poor, consider switching to skin patches.
  • Consider other causes of pain.

Neuropathic pain

  • Described as aching, burning, shooting or stabbing in quality. May be associated with abnormal sensation and allodynia (normal touch felt as painful).
  • Caused by nerve damage due to tumour invasion or compression as well as surgery, chemo and radiotherapy.
  • Often poorly responsive to opioids.
  • Try an adjuvant analgesic: tricyclic antidepressants (eg amitriptyline 10-75 mg nocte) and anticonvulsants (eg carbamazepine 100-200 mg nocte, gabapentin 100 mg nocte titrating up to 600 mg tds) are commonly used.
  • Little evidence for combining adjuvants. Often a second is added if the first has been titrated to an upper limit and pain has only partially responded. Adding a second usually means reducing the dose of the first.
  • Other options include:

Episodic pain

Bony pain due to metastases in the spine, pelvis or femora, exacerbated by walking or weight-bearing can be particularly problematic.

  • Opioids plus NSAIDs are the mainstay, but doses sufficient to control pain on movement cause sedation when the patient is at rest.
  • Advise prn doses of normal release opioid in anticipation of movement.
  • Other options:
    • Radiotherapy
    • Surgical stabilization of pathological fractures
    • Bisphosphonates
    • Epidurals
    • Appropriate appliances and aids

'Total pain'

Pain can be a physical expression of compound psychological/spiritual and social distress and requires a holistic approach.3Consider:



Doctors find the care of terminal patients with resistant pain particularly stressful. Where pain control proves difficult, seek help. Possible sources of advice3 include:

  • Specialist palliative care teams (hospital or hospice based)
  • Macmillan teams
  • GPs with special interest in palliative care


Document references
  1. Colvin L, Forbes K, Fallon M; Difficult pain. BMJ. 2006 May 6;332(7549):1081-3.
  2. Bostrom B, Sandh M, Lundberg D, et al; Cancer-related pain in palliative care: patients' perceptions of pain management. J Adv Nurs. 2004 Feb;45(4):410-9. [abstract]
  3. Supportive and palliative care, NICE (2004)
  4. Gold Standards framework for England; A programme for community palliative care; A standard of excellence for carers.
  5. Liverpool Care Pathway of a Dying Patient (community)
  6. Fallon M, Hanks G, Cherny N; Principles of control of cancer pain. BMJ. 2006 Apr 29;332(7548):1022-4.
  7. Opioid Potency Ratios; Palliative Medicine Handbook (on-line)
  8. Clark AJ, Ahmedzai SH, Allan LG, et al; Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin. 2004 Sep;20(9):1419-28. [abstract]
  9. Symptom Management in advanced cancer by R. Twycross and A. Wilcock (3rd edition) 2001. Radcliffe Medical Press ISBN 1857755103

Internet and further reading Acknowledgements EMIS is grateful to Dr Chloe Borton for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.
DocID: 2563
Document Version: 23
DocRef: bgp1650
Last Updated: 20 Jun 2007
Review Date: 19 Jun 2009

The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest.

Find out more about updating.

(what's this?)

Patient UK Current Health News

Related pages in Patient UK

Your Experience (^ top of page)

 Please add your experience about this condition / medicine
 View Patient Experience for 'Palliation And Terminal Care' (7 there)
 Antidepressants - Tricyclic
 Benefits for the Terminally Ill
 Cancer - A General Overview
 Cancer - Staging and Grading Cancer
 Cancer - What are Cancer and Tumours?
 Cancer - What Causes Cancer?
 Epidurals for Pain Relief After Surgery
 Mouth Care
 Neuropathic Pain
 Smoking - The Facts
 Stem Cell Transplant

Support Group Acorns Children's Hospice Trust
Support Group ACT (Association for Children's Palliative Care)
Support Group Action on Pain
Support Group Bath Centre for Pain Services
Support Group Bob Champion Cancer Trust
Support Group British Pain Society
Support Group CALL - Cancer Aid and Listening Line
Support Group Cancer Black Care
Support Group Cancer Counselling Trust
Support Group Cancer Research UK
Support Group Cancer Support Scotland 'Tak Tent'
Support Group Cancerbackup Scotland
Support Group CancerHelp UK
Support Group Capricorn
Support Group Chai Cancer Care
Support Group Children's Hospice Association Scotland
Support Group Children's Hospices UK
Support Group CLAN Cancer Support
Support Group Dreamflight (for seriously ill children)
Support Group Everyman - action against male cancer
Support Group Gynae C (Gynae Cancer Support)
Support Group Help Adolescents with Cancer
Support Group Help the Hospices
Support Group Hospice Information
Support Group James McDonald Cancer Trust
Support Group Look Good Feel Better
Support Group Macmillan Cancer Support
Support Group Maggie's Centres
Support Group Make a Wish Foundation
Support Group MAP Foundation
Support Group Marie Curie Cancer Care
Support Group Mildmay Hospital UK (Specialist Care for HIV/AIDS)
Support Group Neuropathy Trust
Support Group New Approaches to Cancer
Support Group Orchid
Support Group Over The Wall
Support Group Pain Association Scotland
Support Group Pain Concern
Support Group Pain Relief Foundation
Support Group Penny Brohn Cancer Care
Support Group Rare Cancer Alliance
Support Group Rarer Cancers Forum
Support Group REACT - Rapid Effective Assistance for Children with potentially Terminal illness
Support Group Ruby Care Foundation
Support Group Starlight Children's Foundation UK
Support Group Sue Ryder Care
Support Group Talking Life (self-help audio tapes)
Support Group Tenovus Cancer Information Centre
Support Group UKHCA - UK Home Care Association
Support Group Ulster Cancer Foundation
Support Group Willow Foundation (support for seriously ill young adults)
Support Group World Cancer Research Fund

 Advance Directives (Living Wills)
 Controlled Drugs
 General Aspects of Chemotherapy
 Helping Patients Face Death and Dying
 Looking After People With Cancer
 Nausea and Vomiting in Palliative Care
 Oncological Emergencies
 Pain Relief in Children
 Palliative Care
 Palliative Care of Heart Failure
 Prescribing in Terminal Care
 Radiotherapy - What GPs need to Know
 Syringe Drivers
 Terminal Care
 Tumour Markers

 Guidelines on Cancers
 Guidelines on Palliative Care
 Guidelines on Pain Management

 Cancer
 Cancer in Children
 Hospices
 Tumours

 Stories to Read in the Waiting Room ...

 Links to online videos on Cancers
 Links to online videos on Palliative Care
 National No Smoking Day (video page)

Recent related news items

 Images of cancer cells in motion help in search for treatment
 'Vegetarians get less cancer'
 Vegetarians 'avoid more cancers'
 Animal fats pancreas cancer link
 Ministers to unveil cancer pledge

All news by related topic

 Cancers news
 Palliation And Terminal Care news
 Pain Management news

Medical equipment

 TENS Units

Visit the Patient UK Medical Equipment shop

Books

 Cancer (Challenging) (2nd Edition)
 Cancer (Taking Control of)
 Cancer (Understanding)
 Cancer : British Medical Association's Family Doctor Series
 Cancer Guide for Men (the)
 Cancer. The Facts
 Cancer: At Your Fingertips (3rd Edition)
 Coping Successfully with Pain
 Coping with Chronic Pain: The Complete Guide to Relief
 Managing Arthritis Pain
 Migraine & Other Headaches : British Medical Association's Family Doctor Series
 Migraine and Headaches: Answers At Your Fingertips
 Pain (Coping Successfully with)
 Pain Explained: A Guide for Patients and Carers

Visit the Patient UK shop

Other - Useful resources (^ top of page)

Pictures, diagrams, photos, images, etc.
Evidence based medicine
Online textbooks and journals
UK Guidelines
Online Videos
Medline
Other good health sites

Advertisements











Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>

Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Click here to return to the home page
Click here to read our 'About Us' page
Go to the Emis Access website, where you can book an appointment with your GP, order a repeat prescription or view you medical record online.
Note: this will open in a new window
View and/or join in discussion about health, lifestyle and disease in our interactive forum.
Note: this will open in a new window
Go to our online pharmacy where you can buy over-the-counter products for home delivery.
Note: this will open in a new window
Go to our online newspaper for current medical news and commentary.
Note: this will open in a new window
Adverts on this site do not influence the medical content. Click to read more.
Adverts on this site do not influence the medical content. Click to read more.